DAYVIGO 10 MG TABLET

lemborexant
$11.5877per EA
DEA Schedule CIV

Strength

10 mg/1

Manufacturer

Eisai Inc.

NDC

62856041030

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/12/2026

Active Ingredients

LEMBOREXANT

Approval Type

New Drug (NDA)

FDA Application

NDA212028

On Market Since

4/7/2020

Pharmacological Classes

Cytochrome P450 2B6 Inducers
Orexin Receptor Antagonist
Orexin Receptor Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.9%

1Y

+2.9%

3Y

+13.9%

5Y

+23.8%

All

+32.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.